Open Accessibility Menu
Hide

COVID-19 Antibody Treatment

Hendrick Health offers monoclonal antibody infusion to adult and pediatric patients who are currently diagnosed with COVID-19 and are at high risk for developing severe symptoms or the need for hospitalization.

Criteria for patients to be considered for monoclonal antibody infusion therapy include:

  • Are 12 years of age or older, weighing more than 88lbs
  • Are 65 years of age or older
  • Pregnancy
  • Chronic Kidney Disease
  • Diabetes
  • Immunosuppressive disease or on immunosuppressive treatment
  • Cardiovascular disease (for example: history of heart attack)
  • Hypertension
  • COPD
  • Asthma
  • Interstitial Lung Disease
  • Cystic fibrosis
  • Pulmonary hypertension
  • Sickle cell disease
  • Cerebral palsy
  • Have a tracheostomy or gastrostomy

Requesting an infusion
Talk with your physician to determine if you meet the criteria above to receive a referral or fill out the self-referral form below. After filling out the form below, you will be contacted within 24-48 hours. If this form is submitted after 3 p.m. on Friday, you will be contacted the following Monday. If your symptoms worsen, call you primary care doctor. If this is a medical emergency, dial 9-1-1 or go to the nearest emergency room.

Due to the limited supply of Regeneron from The Department of Health and Human Services, infusion treatment allocation will be limited to the most high-risk patients until allocation of the treatment is increased.

Monoclonal antibody treatment it is not a replacement for vaccination against COVID-19.
Text "covidhelp" to 325-216-4824 or click here to register for a vaccination appointment.


EUA of casirivimab and imdevimad for COVID-19 fact sheet